Global Multiplex PCR Assays Market Growth (Status and Outlook) 2025-2031

According to this study, the global Multiplex PCR Assays market size will reach US$ 2109 million by 2031.

Multiplex PCR, also known as multiplex primer PCR or multiplex PCR, is a PCR reaction in which more than two pairs of primers are added to the same PCR reaction system, and at the same time, multiple nucleic acid fragments are amplified The Reaction Reagent and the operation process are the same as the ordinary PCR. In general, PCR only uses a pair of primers and produces a nucleic acid fragment by PCR amplification, which is mainly used for the identification of single pathogenic factor.Multiplex PCR is mainly used to detect and identify some pathogenic microorganisms, some genetic diseases and genotyping of oncogenes.

United States market for Multiplex PCR Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Multiplex PCR Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Multiplex PCR Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Multiplex PCR Assays players cover Abbott, Siemens, Roche, Agena Bioscience, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Multiplex PCR Assays Industry Forecast” looks at past sales and reviews total world Multiplex PCR Assays sales in 2024, providing a comprehensive analysis by region and market sector of projected Multiplex PCR Assays sales for 2025 through 2031. With Multiplex PCR Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multiplex PCR Assays industry.

This Insight Report provides a comprehensive analysis of the global Multiplex PCR Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Multiplex PCR Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multiplex PCR Assays market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multiplex PCR Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multiplex PCR Assays.

This report presents a comprehensive overview, market shares, and growth opportunities of Multiplex PCR Assays market by product type, application, key players and key regions and countries.

Segmentation by Type:
Products
Services

Segmentation by Application:
Hospitals
Pharmaceutical & Biotechnology Companies
Research Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Siemens
Roche
Agena Bioscience
BD
PerkinElmer
Luminex
QIAGEN
Agilent Technologies
Meso Scale Diagnostics
Randox Laboratories
Seegene
Olink
Illumina
Bio-Rad Laboratories
Abcam
Quanterix

Please note: The report will take approximately 2 business days to prepare and deliver. Show more